Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

被引:3
|
作者
Wang, Saikun [1 ]
Zhu, Ruiting [1 ]
Zhang, Chengwei [2 ]
Guo, Yingze [1 ]
Lv, Mengjiao [1 ]
Zhang, Changyue [1 ]
Bian, Ce [1 ]
Jiang, Ruixue [1 ]
Zhou, Wei [3 ]
Guo, Lirong [1 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Jilin, Peoples R China
[2] Second Hosp Jilin Univ, Dept Anesthesiol, Changchun, Jilin, Peoples R China
[3] First Hosp Jilin Univ, Changchun, Jilin, Peoples R China
来源
PLOS ONE | 2023年 / 18卷 / 10期
关键词
CRITICALLY-ILL PATIENTS; CLINICAL CHARACTERISTICS; MYOCARDIAL INJURY; CRITICAL ILLNESS; MORTALITY; SEVERITY; OUTCOMES; DEATH; PREDICTORS; SARS-COV-2;
D O I
10.1371/journal.pone.0292021
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although studies have shown severe Coronavirus disease 2019 (COVID-19) outcomes in patients with pre-existing coronary heart disease (CHD), the prognosis of COVID-19 patients with pre-existing CHD remains uncertain primarily due to the limited number of patients in existing studies. This study aimed to investigate the impacts of pre-existing CHD on the prognosis of COVID-19 patients. Five electronic databases were searched for eligible studies. This article focused on cohort and case-control studies involving the prognosis of COVID-19 patients with pre-existing CHD. The meta-analysis was performed using a random effects model. The odds ratios (ORs) and 95% confidence intervals (CIs) were used as valid indicators. The study was registered in PROSPERO with the identifier: CRD42022352853. A total of 81 studies, involving 157,439 COVID-19 patients, were included. The results showed that COVID-19 patients with pre-existing CHD exhibited an elevated risk of mortality (OR = 2.45; 95%CI: [2.04, 2.94], P < 0.001), severe/critical COVID-19 (OR = 2.57; 95%CI: [1.98, 3.33], P < 0.001), Intensive Care Unit or Coronary Care Unit (ICU/CCU) admission: (OR = 2.75, 95%CI: [1.61, 4.72], P = 0.002), and reduced odds of discharge/recovery (OR = 0.43, 95%CI: [0.28, 0.66], P < 0.001) compared to COVID-19 patients without pre-existing CHD. Subgroup analyses indicated that the prognosis of COVID-19 patients with pre-existing CHD was influenced by publication year, follow-up duration, gender, and hypertension. In conclusion, pre-existing CHD significantly increases the risk of poor prognosis in patients with COVID-19, particularly in those male or hypertensive patients.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Association of glycosylated hemoglobin and outcomes in patients with COVID-19 and pre-existing type 2 diabetes A protocol for systematic review and meta-analysis
    Zhang, Nie
    Yun, Ruiyuan
    Liu, Lin
    Yang, Liu
    MEDICINE, 2020, 99 (47) : E23392
  • [22] Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis
    Figliozzi, Stefano
    Masci, Pier Giorgio
    Ahmadi, Navid
    Tondi, Lara
    Koutli, Evangelia
    Aimo, Alberto
    Stamatelopoulos, Kimon
    Dimopoulos, Meletios-Athanasios
    Caforio, Alida L. P.
    Georgiopoulos, Georgios
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (10)
  • [23] Prognosis of COVID-19 in patients with breast cancer A protocol for systematic review and meta-analysis
    Sheng, Zhijuan
    Zhang, Li
    Liu, Xinlu
    Yuan, Li
    Li, Fei
    Dai, Dingmei
    Wu, Shuilin
    Yang, Jingzhi
    MEDICINE, 2020, 99 (31)
  • [24] Pre-existing mental health disorders in patients admitted to the intensive care unit: A systematic review and meta-analysis of prevalence
    Pilowsky, Julia K.
    Elliott, Rosalind
    Roche, Michael A.
    JOURNAL OF ADVANCED NURSING, 2021, 77 (05) : 2214 - 2227
  • [25] Mortality risk in patients with obesity and COVID-19 infection: a systematic review and meta-analysis
    Haber, Rachelle
    Ghezzawi, Malak
    Puzantian, Houry
    Haber, Marc
    Saad, Sacha
    Ghandour, Yara
    El Bachour, Joseph
    Yazbeck, Anthony
    Hassanieh, Ghinwa
    Mehdi, Celine
    Ismail, Dima
    Abi-Kharma, Elias
    El-Zein, Ola
    Khamis, Assem
    Chakhtoura, Marlene
    Mantzoros, Christos
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 155
  • [26] Azithromycin in patients with COVID-19: a systematic review and meta-analysis
    Ayerbe, Luis
    Risco-Risco, Carlos
    Forgnone, Ivo
    Perez-Pinar, Maria
    Ayis, Salma
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (02) : 303 - 309
  • [27] Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis
    Singh, Awadhesh Kumar
    Singh, Akriti
    Singh, Ritu
    Misra, Anoop
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 589 - 596
  • [28] Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
    Cheng, Linlin
    Li, Haolong
    Li, Liubing
    Liu, Chenxi
    Yan, Songxin
    Chen, Haizhen
    Li, Yongzhe
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (10)
  • [29] Prediction of prognosis in COVID-19 patients using machine learning: A systematic review and meta-analysis
    Chen, Ruiyao
    Chen, Jiayuan
    Yang, Sen
    Luo, Shuqing
    Xiao, Zhongzhou
    Lu, Lu
    Liang, Bilin
    Liu, Sichen
    Shi, Huwei
    Xu, Jie
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2023, 177
  • [30] Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis
    Abate, Semagn Mekonnen
    Checkol, Yigrem Ali
    Mantefardo, Bahiru
    ANNALS OF MEDICINE AND SURGERY, 2021, 64